FDA Green Lights Potential Functional Cure for Chronic Hep B

(MedPage Today) -- The FDA on Tuesday approved bepirovirsen (Hibsago) as a potential functional cure for adults with chronic hepatitis B, but with no cirrhosis, who are taking antiviral therapy.
Approval was based on findings from the B-Well 1...